Models | Cofactors | Femoral neck BMD | Lumbar BMD | ||
---|---|---|---|---|---|
BMD variation | P | BMD variation | P | ||
1 | Infliximab | 0.027 | 0.001 | 0.030 | 0.001 |
2 | Infliximab | 0.027 | 0.001 | 0.031 | 0.001 |
Male sex | -0.009 | 0.40 | 0.008 | 0.47 | |
Age | 0.002 | 0.56 | 0.005 | 0.09 | |
3 | Infliximab | 0.020 | 0.03 | 0.033 | 0.001 |
Male sex | -0.014 | 0.22 | 0.006 | 0.64 | |
Age | 0.001 | 0.86 | 0.005 | 0.15 | |
Patients on steroids | -0.012 | 0.20 | -0.001 | 0.92 | |
4 | Infliximab | 0.023 | 0.01 | 0.034 | 0.001 |
Male | -0.014 | 0.22 | 0.006 | 0.61 | |
Age | -0.001 | 0.90 | -0.001 | 0.88 | |
Menopause | 0.005 | 0.75 | 0.022 | 0.20 | |
Patients on steroids | -0.010 | 0.29 | -0.002 | 0.87 | |
DAS28 | -0.008 | 0.04 | -0.006 | 0.17 | |
5 | Infliximab | 0.023 | 0.02 | 0.035 | 0.001 |
Male | -0.015 | 0.20 | 0.007 | 0.58 | |
Age | -0.001 | 0.85 | 0.000 | 0.95 | |
Menopause | 0.006 | 0.70 | 0.020 | 0.25 | |
Patients on steroids | -0.009 | 0.37 | -0.004 | 0.65 | |
DAS28 | -0.008 | 0.05 | -0.006 | 0.15 | |
Patients on biphosphonates | -0.012 | 0.29 | 0.022 | 0.07 | |
6 | Infliximab | 0.028 | 0.002 | 0.041 | 0.001 |
Male | -0.007 | 0.53 | 0.010 | 0.39 | |
Age | -0.002 | 0.61 | 0.002 | 0.63 | |
Patients on steroids | -0.008 | 0.35 | -0.001 | 0.91 | |
DAS28 | -0.007 | 0.06 | -0.007 | 0.10 | |
Baseline BMD values | -0.042 | 0.16 | -0.080 | 0.01 |